{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Cox CL"],"funding":["NINR NIH HHS","NCI NIH HHS"],"pagination":["E242-E250"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8925883"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["43(6)"],"pubmed_abstract":["<h4>Purpose/objectives</h4>To document the per survivor and per additional survivor screening costs of a mailed survivorship care plan (SCP) with advanced practice nurse (APN) telephone counseling (SCP+C) or without APN telephone counseling (SCP).
.<h4>Design</h4>Randomized, longitudinal clinical trial.
.<h4>Setting</h4>St. Jude Children's Research Hospital in Memphis, Tennessee.
.<h4>Sample</h4>411 at-risk pediatric cancer survivors (aged 26-59 years), stratified by age (younger than 30 years versus 30 years or older), recommended screening frequency (every one, two, or five years), gender, and cancer diagnosis (hematologic versus solid tumor).
.<h4>Methods</h4>Clinical and resource data costs were derived from trial data and external estimates.
.<h4>Main research variables</h4>The cost-e"],"journal":["Oncology nursing forum"],"pubmed_title":["Increasing Cardiomyopathy Screening in Childhood Cancer Survivors: A Cost Analysis of Advanced Practice Nurse Phone Counseling."],"pmcid":["PMC8925883"],"funding_grant_id":["P30 CA021765","R01 NR011322","U24 CA055727"],"pubmed_authors":["Santucci AK","Hudson MM","Cox CL","Andersen MR","Robison LL"],"additional_accession":[]},"is_claimable":false,"name":"Increasing Cardiomyopathy Screening in Childhood Cancer Survivors: A Cost Analysis of Advanced Practice Nurse Phone Counseling.","description":"<h4>Purpose/objectives</h4>To document the per survivor and per additional survivor screening costs of a mailed survivorship care plan (SCP) with advanced practice nurse (APN) telephone counseling (SCP+C) or without APN telephone counseling (SCP).
.<h4>Design</h4>Randomized, longitudinal clinical trial.
.<h4>Setting</h4>St. Jude Children's Research Hospital in Memphis, Tennessee.
.<h4>Sample</h4>411 at-risk pediatric cancer survivors (aged 26-59 years), stratified by age (younger than 30 years versus 30 years or older), recommended screening frequency (every one, two, or five years), gender, and cancer diagnosis (hematologic versus solid tumor).
.<h4>Methods</h4>Clinical and resource data costs were derived from trial data and external estimates.
.<h4>Main research variables</h4>The cost-e","dates":{"release":"2016-01-01T00:00:00Z","publication":"2016 Nov","modification":"2025-04-04T07:55:03.704Z","creation":"2025-04-04T07:55:03.704Z"},"accession":"S-EPMC8925883","cross_references":{"pubmed":["27768131"],"doi":["10.1188/16.onf.e242-e250","10.1188/16.ONF.E242-E250"]}}